As of Nov 13, 2026. At least 3 observations, ranked by Alpha IQ over 252 trading days. 2,856 eligible records before the optional luck filter.
Link an account to see your stake.
#1 Timothy Regan
0 buys · 34 sales · 252 trading days
Alpha IQ99.3
Why this rank?
32 of 34 worked
Unlikely under model
Unlikely under the luck model.
This rank comes from 0 purchases and 34 sales, measured over 252 trading days after disclosure. It is a sales-only record. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
34 trade dates · 2 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Sold DBXDec 29, 2023$88,630
Stock +3.4%; recorded comparison +33.8%; outcome in the trade's direction +30.4%.
1 reported line and filing sources
Dec 29, 2023 · $88,630 · Form 4Stock +3.4% versus the recorded factor comparison +33.8%.
Sold DBXDec 15, 2023$88,222
Stock -1.1%; recorded comparison +26.0%; outcome in the trade's direction +27.1%.
1 reported line and filing sources
Dec 15, 2023 · $88,222 · Form 4Stock -1.1% versus the recorded factor comparison +26.0%.
Sold DBXNov 30, 2023$84,217
Stock +1.3%; recorded comparison +24.1%; outcome in the trade's direction +22.8%.
1 reported line and filing sources
Nov 30, 2023 · $84,217 · Form 4Stock +1.3% versus the recorded factor comparison +24.1%.
Sold DBXJan 16, 2024$93,863
Stock -1.7%; recorded comparison +29.8%; outcome in the trade's direction +31.5%.
1 reported line and filing sources
Jan 16, 2024 · $93,863 · Form 4Stock -1.7% versus the recorded factor comparison +29.8%.
Sold DBXDec 13, 2024$74,975
Stock -6.9%; recorded comparison +6.0%; outcome in the trade's direction +12.9%.
1 reported line and filing sources
Dec 13, 2024 · $74,975 · Form 4Stock -6.9% versus the recorded factor comparison +6.0%.
Sold DBXOct 15, 2024$65,443
Stock +13.1%; recorded comparison +18.8%; outcome in the trade's direction +5.7%.
1 reported line and filing sources
Oct 15, 2024 · $65,443 · Form 4Stock +13.1% versus the recorded factor comparison +18.8%.
Sold DBXMar 27, 2024$73,074
Stock +13.0%; recorded comparison +22.0%; outcome in the trade's direction +9.0%.
1 reported line and filing sources
Mar 27, 2024 · $73,074 · Form 4Stock +13.0% versus the recorded factor comparison +22.0%.
Sold DBXAug 30, 2024$75,443
Stock +27.6%; recorded comparison +31.0%; outcome in the trade's direction +3.4%.
1 reported line and filing sources
Aug 30, 2024 · $75,443 · Form 4Stock +27.6% versus the recorded factor comparison +31.0%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001734440. Profile company CIK 0001467623. DROPBOX, INC.
Recorded role: CFO · DBX.
34 obs. Confidence 99; 252-day hit rate 94.1%. Confidence measures the sample, not a probability of future success.
Separate past-calls measure (3 months · sample 21.7):
Past calls: 60% directionally correct over 3 months (adjusted toward 50% peer prior; 70% observed; recency-weighted sample 21.7)
Descriptive statistic of past trades, not a prediction
How to read these past calls · As of 2026-11-13
Bullish calls are correct after outperformance; bearish calls are correct after underperformance, relative to SPY. Only directional buy and sell signals are graded. Gifts, grants and tax withholding are excluded. Recent outcomes receive more weight, with a half-life of 252 trading days. The peer prior contributes 24 equivalent outcomes. The weighted sample is not a count of trades.
Luck reference: 32 of 34 represented trade dates; upper tail 2.548e-5; corrected within the horizon 1.055e-2, across 24734 person/horizon comparisons 3.655e-2. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 2 windows, with 2 wins and upper tail 3.905e-1.
This rank comes from 19 purchases and 0 sales, measured over 252 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
19 trade dates · 2 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought BWFGMay 30, 2024$1,602
Stock +41.7%; recorded comparison +19.7%; outcome in the trade's direction +22.0%.
1 reported line and filing sources
May 30, 2024 · $1,602 · Form 4Stock +41.7% versus the recorded factor comparison +19.7%.
Bought BWFGDec 6, 2024$7,567
Stock +49.2%; recorded comparison +39.6%; outcome in the trade's direction +9.6%.
1 reported line and filing sources
Dec 6, 2024 · $7,567 · Form 4Stock +49.2% versus the recorded factor comparison +39.6%.
Bought BWFGSep 10, 2024$3,857
Stock +49.2%; recorded comparison +42.8%; outcome in the trade's direction +6.4%.
1 reported line and filing sources
Sep 10, 2024 · $3,857 · Form 4Stock +49.2% versus the recorded factor comparison +42.8%.
Bought BWFGDec 14, 2023$15,455
Stock +8.2%; recorded comparison +18.5%; outcome in the trade's direction -10.2%.
1 reported line and filing sources
Dec 14, 2023 · $15,455 · Form 4Stock +8.2% versus the recorded factor comparison +18.5%.
Bought BWFGMay 28, 2024$45,109
Stock +42.8%; recorded comparison +21.4%; outcome in the trade's direction +21.4%.
1 reported line and filing sources
May 28, 2024 · $45,109 · Form 4Stock +42.8% versus the recorded factor comparison +21.4%.
Bought BWFGMay 22, 2024$486
Stock +44.9%; recorded comparison +21.5%; outcome in the trade's direction +23.4%.
1 reported line and filing sources
May 22, 2024 · $486 · Form 4Stock +44.9% versus the recorded factor comparison +21.5%.
Bought BWFGSep 6, 2024$3,263
Stock +53.5%; recorded comparison +44.9%; outcome in the trade's direction +8.7%.
1 reported line and filing sources
Sep 6, 2024 · $3,263 · Form 4Stock +53.5% versus the recorded factor comparison +44.9%.
Bought BWFGSep 11, 2024$3,924
Stock +43.7%; recorded comparison +38.2%; outcome in the trade's direction +5.5%.
1 reported line and filing sources
Sep 11, 2024 · $3,924 · Form 4Stock +43.7% versus the recorded factor comparison +38.2%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001026081. Profile company CIK 0001505732. Bankwell Financial Group, Inc.
19 obs. Confidence 91; 252-day hit rate 89.5%. Confidence measures the sample, not a probability of future success.
Separate past-calls measure (3 months · sample 78.4):
Past calls: 73% directionally correct over 3 months (adjusted toward 50% peer prior; 79% observed; recency-weighted sample 78.4)
Descriptive statistic of past trades, not a prediction
How to read these past calls · As of 2026-11-13
Bullish calls are correct after outperformance; bearish calls are correct after underperformance, relative to SPY. Only directional buy and sell signals are graded. Gifts, grants and tax withholding are excluded. Recent outcomes receive more weight, with a half-life of 252 trading days. The peer prior contributes 24 equivalent outcomes. The weighted sample is not a count of trades.
Luck reference: 17 of 19 represented trade dates; upper tail 1.520e-6; corrected within the horizon 1.447e-3, across 24734 person/horizon comparisons 4.700e-3. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 2 windows, with 1 wins and upper tail 5.806e-1.
This rank comes from 15 purchases and 0 sales, measured over 252 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
16 trade dates · 1 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought BEEPApr 16, 2024$4,258
Stock +17.2%; recorded comparison -48.4%; outcome in the trade's direction +65.6%.
1 reported line and filing sources
Apr 16, 2024 · $4,258 · Form 4Stock +17.2% versus the recorded factor comparison -48.4%.
Bought BEEPApr 18, 2024$112,677
Stock +28.9%; recorded comparison -42.1%; outcome in the trade's direction +71.0%.
1 reported line and filing sources
Apr 18, 2024 · $112,677 · Form 4Stock +28.9% versus the recorded factor comparison -42.1%.
Bought BEEPMay 3, 2024$1,957
Stock +14.0%; recorded comparison -45.7%; outcome in the trade's direction +59.7%.
1 reported line and filing sources
May 3, 2024 · $1,957 · Form 4Stock +14.0% versus the recorded factor comparison -45.7%.
Bought BEEPMay 20, 2024$32,719
Stock +9.9%; recorded comparison -53.1%; outcome in the trade's direction +62.9%.
1 reported line and filing sources
May 20, 2024 · $32,719 · Form 4Stock +9.9% versus the recorded factor comparison -53.1%.
Bought BEEPApr 25, 2024$350
Stock +5.0%; recorded comparison -46.7%; outcome in the trade's direction +51.7%.
1 reported line and filing sources
Apr 25, 2024 · $350 · Form 4Stock +5.0% versus the recorded factor comparison -46.7%.
Bought BEEPApr 24, 2024$5,342
Stock +14.8%; recorded comparison -43.3%; outcome in the trade's direction +58.0%.
1 reported line and filing sources
Apr 24, 2024 · $5,342 · Form 4Stock +14.8% versus the recorded factor comparison -43.3%.
Bought BEEPMay 17, 2024$4,129
Stock +11.1%; recorded comparison -54.0%; outcome in the trade's direction +65.1%.
1 reported line and filing sources
May 17, 2024 · $4,129 · Form 4Stock +11.1% versus the recorded factor comparison -54.0%.
Bought BEEPMay 24, 2024$29,895
Stock +15.6%; recorded comparison -47.6%; outcome in the trade's direction +63.2%.
1 reported line and filing sources
May 24, 2024 · $29,895 · Form 4Stock +15.6% versus the recorded factor comparison -47.6%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 1879349. Profile company CIK ticker:BEEP. BEEP
15 obs. Confidence 85; 252-day hit rate 100.0%. Confidence measures the sample, not a probability of future success.
Luck reference: 15 of 15 represented trade dates; upper tail 1.607e-7; corrected within the horizon 4.589e-4, across 24734 person/horizon comparisons 1.359e-3. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 1 windows, with 1 wins and upper tail 3.524e-1.
This rank comes from 14 purchases and 0 sales, measured over 252 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
15 trade dates · 2 nonoverlapping windows · 2 stocks. Shared stock moves and overlapping windows are not separate tests of skill.
Bought ARQTMay 21, 2025$34,423
Stock +51.3%; recorded comparison +46.3%; outcome in the trade's direction +5.0%.
1 reported line and filing sources
May 21, 2025 · $34,423 · Form 4Stock +51.3% versus the recorded factor comparison +46.3%.
Bought MIRMMar 6, 2025$58,597
Stock +113.3%; recorded comparison +83.0%; outcome in the trade's direction +30.3%.
1 reported line and filing sources
Mar 6, 2025 · $58,597 · Form 4Stock +113.3% versus the recorded factor comparison +83.0%.
Bought MIRMMar 14, 2025$24,214
Stock +104.7%; recorded comparison +73.5%; outcome in the trade's direction +31.2%.
2 reported lines and filing sources
Mar 14, 2025 · $23,291 · Form 4Stock +104.7% versus the recorded factor comparison +73.5%.
Mar 17, 2025 · $923 · Form 4Stock +104.7% versus the recorded factor comparison +73.5%.
Bought MIRMNov 9, 2023$82,353
Stock +52.5%; recorded comparison +38.0%; outcome in the trade's direction +14.5%.
1 reported line and filing sources
Nov 9, 2023 · $82,353 · Form 4Stock +52.5% versus the recorded factor comparison +38.0%.
Bought MIRMSep 18, 2024$4,301
Stock +90.6%; recorded comparison +55.1%; outcome in the trade's direction +35.5%.
1 reported line and filing sources
Sep 18, 2024 · $4,301 · Form 4Stock +90.6% versus the recorded factor comparison +55.1%.
Bought MIRMSep 6, 2024$9,563
Stock +77.9%; recorded comparison +49.4%; outcome in the trade's direction +28.5%.
1 reported line and filing sources
Sep 6, 2024 · $9,563 · Form 4Stock +77.9% versus the recorded factor comparison +49.4%.
Bought ARQTJun 13, 2025$34,610
Stock +97.7%; recorded comparison +85.9%; outcome in the trade's direction +11.7%.
1 reported line and filing sources
Jun 13, 2025 · $34,610 · Form 4Stock +97.7% versus the recorded factor comparison +85.9%.
Bought ARQTMay 15, 2025$34,317
Stock +39.8%; recorded comparison +38.7%; outcome in the trade's direction +1.1%.
1 reported line and filing sources
May 15, 2025 · $34,317 · Form 4Stock +39.8% versus the recorded factor comparison +38.7%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001365617. Profile company CIK 0001787306. Arcutis Biotherapeutics, Inc.
Recorded role: Director · ARQT.
14 obs. Confidence 83; 252-day hit rate 100.0%. Confidence measures the sample, not a probability of future success.
Luck reference: 14 of 14 represented trade dates; upper tail 4.560e-7; corrected within the horizon 6.511e-4, across 24734 person/horizon comparisons 1.880e-3. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 2 windows, with 2 wins and upper tail 1.242e-1.
This rank comes from 14 purchases and 0 sales, measured over 252 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
14 trade dates · 1 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought UBFOJun 11, 2024$59,436
Stock +12.0%; recorded comparison +10.2%; outcome in the trade's direction +1.9%.
1 reported line and filing sources
Jun 11, 2024 · $59,436 · Form 4Stock +12.0% versus SPY +10.2%.
Bought UBFOJun 6, 2024$32,937
Stock +18.7%; recorded comparison +12.8%; outcome in the trade's direction +5.9%.
1 reported line and filing sources
Jun 6, 2024 · $32,937 · Form 4Stock +18.7% versus SPY +12.8%.
Bought UBFOJun 5, 2024$5,126
Stock +17.1%; recorded comparison +12.2%; outcome in the trade's direction +4.9%.
1 reported line and filing sources
Jun 5, 2024 · $5,126 · Form 4Stock +17.1% versus SPY +12.2%.
Bought UBFOJun 4, 2024$6,083
Stock +18.9%; recorded comparison +13.4%; outcome in the trade's direction +5.5%.
1 reported line and filing sources
Jun 4, 2024 · $6,083 · Form 4Stock +18.9% versus SPY +13.4%.
Bought UBFOJun 3, 2024$1,827
Stock +13.5%; recorded comparison +12.4%; outcome in the trade's direction +1.1%.
1 reported line and filing sources
Jun 3, 2024 · $1,827 · Form 4Stock +13.5% versus SPY +12.4%.
Bought UBFOMay 29, 2024$16,994
Stock +16.6%; recorded comparison +14.1%; outcome in the trade's direction +2.5%.
1 reported line and filing sources
May 29, 2024 · $16,994 · Form 4Stock +16.6% versus SPY +14.1%.
Bought UBFOMay 17, 2024$7,903
Stock +20.9%; recorded comparison +10.0%; outcome in the trade's direction +10.9%.
1 reported line and filing sources
May 17, 2024 · $7,903 · Form 4Stock +20.9% versus SPY +10.0%.
Bought UBFOMay 13, 2024$6,018
Stock +21.8%; recorded comparison +12.3%; outcome in the trade's direction +9.6%.
1 reported line and filing sources
May 13, 2024 · $6,018 · Form 4Stock +21.8% versus SPY +12.3%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001981173. Profile company CIK 0001127371. Community West Bancshares
14 obs. Confidence 83; 252-day hit rate 92.9%. Confidence measures the sample, not a probability of future success.
Luck reference: 13 of 14 represented trade dates; upper tail 1.219e-5; corrected within the horizon 8.700e-3, across 24734 person/horizon comparisons 2.248e-2. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 1 windows, with 1 wins and upper tail 3.524e-1.
This rank comes from 10 purchases and 0 sales, measured over 252 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
11 trade dates · 1 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought GLSIJan 10, 2025$31,275
Stock +138.9%; recorded comparison +87.0%; outcome in the trade's direction +51.9%.
1 reported line and filing sources
Jan 10, 2025 · $31,275 · Form 4Stock +138.9% versus the recorded factor comparison +87.0%.
Bought GLSIJan 6, 2025$39,391
Stock +101.0%; recorded comparison +61.9%; outcome in the trade's direction +39.1%.
2 reported lines and filing sources
Jan 6, 2025 · $14,641 · Form 4Stock +101.0% versus the recorded factor comparison +61.9%.
Jan 7, 2025 · $24,750 · Form 4Stock +101.0% versus the recorded factor comparison +61.9%.
Bought GLSIJan 3, 2025$44,030
Stock +83.1%; recorded comparison +54.8%; outcome in the trade's direction +28.2%.
1 reported line and filing sources
Jan 3, 2025 · $44,030 · Form 4Stock +83.1% versus the recorded factor comparison +54.8%.
Bought GLSIJan 2, 2025$23,940
Stock +70.9%; recorded comparison +51.5%; outcome in the trade's direction +19.5%.
1 reported line and filing sources
Jan 2, 2025 · $23,940 · Form 4Stock +70.9% versus the recorded factor comparison +51.5%.
Bought GLSIDec 31, 2024$27,264
Stock +93.9%; recorded comparison +69.5%; outcome in the trade's direction +24.4%.
1 reported line and filing sources
Dec 31, 2024 · $27,264 · Form 4Stock +93.9% versus the recorded factor comparison +69.5%.
Bought GLSIDec 30, 2024$35,584
Stock +74.9%; recorded comparison +69.2%; outcome in the trade's direction +5.7%.
1 reported line and filing sources
Dec 30, 2024 · $35,584 · Form 4Stock +74.9% versus the recorded factor comparison +69.2%.
Bought GLSIApr 25, 2025$35,568
Stock +128.0%; recorded comparison +63.2%; outcome in the trade's direction +64.8%.
1 reported line and filing sources
Apr 25, 2025 · $35,568 · Form 4Stock +128.0% versus the recorded factor comparison +63.2%.
Bought GLSIApr 17, 2025$48,492
Stock +145.8%; recorded comparison +83.4%; outcome in the trade's direction +62.4%.
1 reported line and filing sources
Apr 17, 2025 · $48,492 · Form 4Stock +145.8% versus the recorded factor comparison +83.4%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001806920. Profile company CIK 0001799788. Greenwich LifeSciences, Inc.
Recorded role: CEO · GLSI.
10 obs. Confidence 71; 252-day hit rate 100.0%. Confidence measures the sample, not a probability of future success.
Separate past-calls measure (3 months · sample 17.2):
Past calls: 51% directionally correct over 3 months (adjusted toward 50% peer prior; 52% observed; recency-weighted sample 17.2)
Descriptive statistic of past trades, not a prediction
How to read these past calls · As of 2026-11-13
Bullish calls are correct after outperformance; bearish calls are correct after underperformance, relative to SPY. Only directional buy and sell signals are graded. Gifts, grants and tax withholding are excluded. Recent outcomes receive more weight, with a half-life of 252 trading days. The peer prior contributes 24 equivalent outcomes. The weighted sample is not a count of trades.
Luck reference: 10 of 10 represented trade dates; upper tail 2.956e-5; corrected within the horizon 1.055e-2, across 24734 person/horizon comparisons 3.655e-2. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 1 windows, with 1 wins and upper tail 3.524e-1.
This rank comes from 10 purchases and 0 sales, measured over 252 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
10 trade dates · 2 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought TKONov 14, 2023$999,974
Stock +47.4%; recorded comparison +29.9%; outcome in the trade's direction +17.5%.
1 reported line and filing sources
Nov 14, 2023 · $999,974 · Form 4Stock +47.4% versus the recorded factor comparison +29.9%.
Bought TKOApr 9, 2024$146,240,760
Stock +51.7%; recorded comparison +22.1%; outcome in the trade's direction +29.6%.
1 reported line and filing sources
Apr 9, 2024 · $146,240,760 · Form 4Stock +51.7% versus the recorded factor comparison +22.1%.
Bought TKODec 16, 2024$1,377,450
Stock +51.6%; recorded comparison +15.9%; outcome in the trade's direction +35.7%.
1 reported line and filing sources
Dec 16, 2024 · $1,377,450 · Form 4Stock +51.6% versus the recorded factor comparison +15.9%.
Bought TKODec 11, 2024$4,270,126
Stock +49.1%; recorded comparison +14.7%; outcome in the trade's direction +34.4%.
1 reported line and filing sources
Dec 11, 2024 · $4,270,126 · Form 4Stock +49.1% versus the recorded factor comparison +14.7%.
Bought TKOFeb 10, 2025$643,656
Stock +17.0%; recorded comparison -12.1%; outcome in the trade's direction +29.1%.
1 reported line and filing sources
Feb 10, 2025 · $643,656 · Form 4Stock +17.0% versus the recorded factor comparison -12.1%.
Bought TKOFeb 5, 2025$727,444
Stock +28.7%; recorded comparison -1.5%; outcome in the trade's direction +30.2%.
1 reported line and filing sources
Feb 5, 2025 · $727,444 · Form 4Stock +28.7% versus the recorded factor comparison -1.5%.
Bought TKOJan 17, 2025$8,738,971
Stock +43.4%; recorded comparison +7.5%; outcome in the trade's direction +35.8%.
1 reported line and filing sources
Jan 17, 2025 · $8,738,971 · Form 4Stock +43.4% versus the recorded factor comparison +7.5%.
Bought TKOJan 31, 2025$3,654,514
Stock +32.0%; recorded comparison -2.3%; outcome in the trade's direction +34.2%.
1 reported line and filing sources
Jan 31, 2025 · $3,654,514 · Form 4Stock +32.0% versus the recorded factor comparison -2.3%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001320234. Profile company CIK 0001973266. TKO Group Holdings, Inc.
Recorded role: Chief Executive Officer · TKO.
10 obs. Confidence 71; 252-day hit rate 100.0%. Confidence measures the sample, not a probability of future success.
Luck reference: 10 of 10 represented trade dates; upper tail 2.956e-5; corrected within the horizon 1.055e-2, across 24734 person/horizon comparisons 3.655e-2. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 2 windows, with 2 wins and upper tail 1.242e-1.
This rank comes from 10 purchases and 0 sales, measured over 252 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
11 trade dates · 1 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought CSBRDec 20, 2023$10,122
Stock +65.2%; recorded comparison +25.8%; outcome in the trade's direction +39.4%.
1 reported line and filing sources
Dec 20, 2023 · $10,122 · Form 4Stock +65.2% versus SPY +25.8%.
Bought CSBRJan 8, 2024$6,150
Stock +51.8%; recorded comparison +22.5%; outcome in the trade's direction +29.3%.
1 reported line and filing sources
Jan 8, 2024 · $6,150 · Form 4Stock +51.8% versus SPY +22.5%.
Bought CSBRJan 4, 2024$30,540
Stock +57.3%; recorded comparison +24.2%; outcome in the trade's direction +33.1%.
2 reported lines and filing sources
Jan 4, 2024 · $18,360 · Form 4Stock +57.3% versus SPY +24.2%.
Jan 5, 2024 · $12,180 · Form 4Stock +57.3% versus SPY +24.2%.
Bought CSBRDec 21, 2023$12,300
Stock +61.7%; recorded comparison +26.4%; outcome in the trade's direction +35.3%.
1 reported line and filing sources
Dec 21, 2023 · $12,300 · Form 4Stock +61.7% versus SPY +26.4%.
Bought CSBRDec 19, 2023$23,750
Stock +51.1%; recorded comparison +26.2%; outcome in the trade's direction +24.9%.
1 reported line and filing sources
Dec 19, 2023 · $23,750 · Form 4Stock +51.1% versus SPY +26.2%.
Bought CSBRJan 12, 2024$6,500
Stock +46.8%; recorded comparison +24.6%; outcome in the trade's direction +22.2%.
1 reported line and filing sources
Jan 12, 2024 · $6,500 · Form 4Stock +46.8% versus SPY +24.6%.
Bought CSBRJan 11, 2024$12,540
Stock +37.7%; recorded comparison +24.4%; outcome in the trade's direction +13.3%.
1 reported line and filing sources
Jan 11, 2024 · $12,540 · Form 4Stock +37.7% versus SPY +24.4%.
Bought CSBRJan 10, 2024$18,577
Stock +55.7%; recorded comparison +22.2%; outcome in the trade's direction +33.5%.
1 reported line and filing sources
Jan 10, 2024 · $18,577 · Form 4Stock +55.7% versus SPY +22.2%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001327897. Profile company CIK 0000771856. CHAMPIONS ONCOLOGY, INC.
10 obs. Confidence 71; 252-day hit rate 100.0%. Confidence measures the sample, not a probability of future success.
Luck reference: 10 of 10 represented trade dates; upper tail 2.956e-5; corrected within the horizon 1.055e-2, across 24734 person/horizon comparisons 3.655e-2. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 1 windows, with 1 wins and upper tail 3.524e-1.
One entry per filing selected from the current 90-day scored feed. Derivatives and known open-market trades below $10,000 are excluded from conviction scoring. These are reported transactions, not live trades. A trade score and an insider's historical Alpha IQ measure different things.